» Articles » PMID: 28584650

Are Men Under-treated and Women Over-treated with Antidepressants? Findings from a Cross-sectional Survey in Sweden

Overview
Journal BJPsych Bull
Specialty Psychiatry
Date 2017 Jun 7
PMID 28584650
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

To examine gender differences in self-reported depression and prescribed antidepressants (ADs). The Hospital Anxiety and Depression Scale was used to assess depression, and information on prescribed ADs was obtained from the Swedish Prescribed Drug Register. Depression was reported by 11.7% of the participants (12.3% men and 11.2% women). ADs were prescribed for 7.6% of the participants (5.3% men, 9.8% women). Among men, 1.8% reported depression and used ADs, 10.5% reported depression but did not use ADs, and 3.6% used ADs but did not report depression. The corresponding figures for women were 2.6%, 8.6% and 7.2%. Men report depression to a greater extent than women but are prescribed ADs to a lesser extent, possibly a sign of under-treatment. Women are prescribed ADs without reporting depression more often than men, possibly a sign of over-treatment. Although the causes remain unclear, diagnostic and treatment guidelines should benefit from considering gender differences in these respects.

Citing Articles

A real-world analysis of antidepressant medications in US veterans aged 60 years and older: a comparative analysis.

Pittman R, Sutton S, Magagnoli J, Cummings T J Comp Eff Res. 2025; 14(2):e240187.

PMID: 39836031 PMC: 11773886. DOI: 10.57264/cer-2024-0187.


The epidemiology of major depression among adults in Norway: an observational study on the concurrence between population surveys and registry data - a NCDNOR project.

Bramness J, Hjellvik V, Hoye A, Tesli M, Haram M, Nystad W BMC Public Health. 2024; 24(1):1330.

PMID: 38755615 PMC: 11100182. DOI: 10.1186/s12889-024-18754-w.


How gender and low mental health literacy are related to unmet need for mental healthcare: a cross-sectional population-based study in Sweden.

Blom S, Lindh F, Lundin A, Burstrom B, Hensing G, Love J Arch Public Health. 2024; 82(1):12.

PMID: 38273389 PMC: 10809616. DOI: 10.1186/s13690-023-01228-7.


Age-Dependent Sex Differences in the Prevalence of Selective Serotonin Reuptake Inhibitor Treatment: A Retrospective Cohort Analysis.

Sanchez-Ruiz J, Leibman N, Larson N, Jenkins G, Ahmed A, Nunez N J Womens Health (Larchmt). 2023; 32(11):1229-1240.

PMID: 37856151 PMC: 10621660. DOI: 10.1089/jwh.2022.0484.


Prevalence of antidepressant use in Brazil: a systematic review with meta-analysis.

Tiguman G, Hoefler R, Silva M, Lima V, Ribeiro-Vaz I, Galvao T Braz J Psychiatry. 2023; 46:e20233095.

PMID: 37718462 PMC: 11189131. DOI: 10.47626/1516-4446-2023-3095.


References
1.
Keers R, Aitchison K . Gender differences in antidepressant drug response. Int Rev Psychiatry. 2010; 22(5):485-500. DOI: 10.3109/09540261.2010.496448. View

2.
Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine J . Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA. 2004; 291(21):2581-90. DOI: 10.1001/jama.291.21.2581. View

3.
Owens G . Gender differences in health care expenditures, resource utilization, and quality of care. J Manag Care Pharm. 2008; 14(3 Suppl):2-6. PMC: 10438189. DOI: 10.18553/jmcp.2008.14.S6-A.2. View

4.
Abbing-Karahagopian V, Huerta C, Souverein P, de Abajo F, Leufkens H, Slattery J . Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol. 2014; 70(7):849-57. DOI: 10.1007/s00228-014-1676-z. View

5.
Fournier J, DeRubeis R, Hollon S, Dimidjian S, Amsterdam J, Shelton R . Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010; 303(1):47-53. PMC: 3712503. DOI: 10.1001/jama.2009.1943. View